Zhong Wang, M.D.

CONTACT

Jun Liu, Ph.D.

CONTACT

Lead Sponsor

Zhong Wang

Age

18 - No limit years

Sex

ALL

Healthy Volunteers

No

•Clinical diagnosis of viral pneumonia;
•Clinical diagnosis of Shi-du-yun-jie Zheng (damp stagnation syndrome) according to Chinese medicine, including fever,cough,sore throat,stuffy chest,irritability and thirst,short yellow urine,constipation or loose stool,thick and greasy yellow coating,and slippery pulse;
•Chest CT showed signs of acute exudative pneumonia in the lungs;
•Over 18 years old, regardless of gender, voluntarily signed an informed consent form;
•Those who were hospitalized and were accompanied by fever (body temperature ≥37.3℃) and respiratory tract symptoms like cough or dyspnea, when they were enrolled.

•Patients that are susceptible to sensitivity or known to be allergic to the study drug;
•Patients whose white blood cell count ≥12×10\^9 or neutrophil percentage ≥80%;
•Patients whose weight is less than 40 kg;
•Patients with respiratory failure or need mechanical ventilation;
•Patients with shock;
•Patients required to be in ICU monitoring and treatment;
•Patients participated in other clinical trials within 1 month;
•Patients with known renal impairment;
•Patients with any of the following laboratory parameter abnormalities during the screening period or within 24 hours before screening: ALT or AST level\> 5 times the upper limit of normal range (ULN) or-ALT or AST level \> 3 times ULN and total bilirubin level\> 2 times ULN;
•Patients with immune system diseases and long-term use of immunosuppressive agents;
•Pregnant or breastfeeding women, or who have a positive pregnancy test during the screening period, or plan to become pregnant within 3 months after the study treatment.